Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
[9] Chambers ES, Preston T, Frost G, Morrison DJ
& Donath, M
All three funds also have relatively high expense ratios: OZEM and THNRs ratios sit at 0.59%, while HRTS has a whopping 0.75% fee: OZEM launched in May 2024 and has $37 million in AUM
Common Side Effects Comparison The nausea and diarrhea rates are noticeably higher with retatrutide at maximum dose (~45% vs ~31% for nausea)
1 Rybelsus delivers lower exposure to semaglutide than the injectable form tested in that trial, meaning the difference in practice is likely even larger
US$ 25.42
US$ 25.35
US$ 24.75
US$ 24.74
US$ 21.12
US$ 29.43
